SG11201701292XA - Topical formulation - Google Patents
Topical formulationInfo
- Publication number
- SG11201701292XA SG11201701292XA SG11201701292XA SG11201701292XA SG11201701292XA SG 11201701292X A SG11201701292X A SG 11201701292XA SG 11201701292X A SG11201701292X A SG 11201701292XA SG 11201701292X A SG11201701292X A SG 11201701292XA SG 11201701292X A SG11201701292X A SG 11201701292XA
- Authority
- SG
- Singapore
- Prior art keywords
- topical formulation
- topical
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462042600P | 2014-08-27 | 2014-08-27 | |
PCT/US2015/047152 WO2016033308A1 (fr) | 2014-08-27 | 2015-08-27 | Formulation topique |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201701292XA true SG11201701292XA (en) | 2017-03-30 |
Family
ID=54062832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201701292XA SG11201701292XA (en) | 2014-08-27 | 2015-08-27 | Topical formulation |
Country Status (10)
Country | Link |
---|---|
US (1) | US20170266289A1 (fr) |
EP (1) | EP3185852A1 (fr) |
JP (3) | JP2017529334A (fr) |
CN (1) | CN106794126A (fr) |
AU (3) | AU2015308878A1 (fr) |
BR (1) | BR112017004032A2 (fr) |
CA (1) | CA2957579A1 (fr) |
MX (1) | MX2017002438A (fr) |
SG (1) | SG11201701292XA (fr) |
WO (1) | WO2016033308A1 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3060234A1 (fr) * | 2013-10-24 | 2016-08-31 | AbbVie Inc. | Inhibiteur sélectif de jak1 et ses utilisations |
US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
CN116284011A (zh) | 2015-10-16 | 2023-06-23 | 艾伯维公司 | 制备咪唑并[1,2-a]吡咯并[2,3-e]吡嗪类化合物及其固态形式的方法 |
US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11773106B2 (en) | 2015-10-16 | 2023-10-03 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
CN105833279B (zh) * | 2016-05-30 | 2021-06-22 | 傅远桥 | 皮肤多种损伤创面治疗的外用药物组合物及其制备方法 |
JP2018048133A (ja) * | 2016-09-20 | 2018-03-29 | 参天製薬株式会社 | 炎症性眼疾患の治療及び/又は予防剤 |
JP2018048134A (ja) * | 2016-09-20 | 2018-03-29 | 参天製薬株式会社 | Jak阻害剤を含有する点眼剤 |
WO2018105755A1 (fr) * | 2016-12-05 | 2018-06-14 | 정한수 | Produit cosmétique contenant des nanoparticules renfermant à l'état encapsulé un principe actif améliorant le blanchiment, et procédé de production dudit produit cosmétique |
AU2018230500B2 (en) | 2017-03-09 | 2024-03-07 | Abbvie Inc. | Methods of treating Crohn's disease and ulcerative colitis |
US11564922B2 (en) | 2017-03-09 | 2023-01-31 | Abbvie Inc. | Methods of treating crohn's disease and ulcerative colitis |
US9987239B1 (en) * | 2017-03-14 | 2018-06-05 | Rey Ventures, LLC | Pharmaceutical retinoid preparation for topical use |
US20200155524A1 (en) | 2018-11-16 | 2020-05-21 | Arcutis, Inc. | Method for reducing side effects from administration of phosphodiesterase-4 inhibitors |
US12011437B1 (en) | 2017-06-07 | 2024-06-18 | Arcutis Biotherapeutics, Inc. | Roflumilast formulations with an improved pharmacokinetic profile |
US11129818B2 (en) | 2017-06-07 | 2021-09-28 | Arcutis Biotherapeutics, Inc. | Topical roflumilast formulation having improved delivery and plasma half life |
US12042487B2 (en) | 2018-11-16 | 2024-07-23 | Arcutis Biotherapeutics, Inc. | Method for reducing side effects from administration of phosphodiesterase-4 inhibitors |
US9895359B1 (en) | 2017-06-07 | 2018-02-20 | Arcutis, Inc. | Inhibition of crystal growth of roflumilast |
US20210161870A1 (en) | 2017-06-07 | 2021-06-03 | Arcutis Biotherapeutics, Inc. | Roflumilast formulations with an improved pharmacokinetic profile |
US11534493B2 (en) * | 2017-09-22 | 2022-12-27 | Arcutis Biotherapeutics, Inc. | Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents |
US11241378B2 (en) * | 2017-11-20 | 2022-02-08 | Jiangsu Hengrui Medicine Co., Ltd. | Pharmaceutical JAK kinase inhibitor and diethylene glycol composition for topical administration and preparation method therefor |
WO2019123282A1 (fr) * | 2017-12-22 | 2019-06-27 | Qatar University | Nanoémulgels non aqueux transdermiques pour administration systémique d'inhibiteur de l'aromatase |
WO2019236374A2 (fr) | 2018-06-04 | 2019-12-12 | Arcutis, Inc. | Méthode et formulation pour améliorer le temps de latence de pénétration de la peau du roflumilast |
CN109806385B (zh) * | 2019-01-31 | 2022-04-08 | 浙江圣兆药物科技股份有限公司 | 一种醋酸亮丙瑞林微球制剂及其制备方法 |
CN113453758A (zh) * | 2019-02-27 | 2021-09-28 | 国立大学法人大阪大学 | 脉管异常治疗用外用剂 |
JP2022525221A (ja) | 2019-03-14 | 2022-05-11 | クレシタ セラピューティクス インコーポレイテッド | 洗い流し組成物および活性剤を送達するためのそれらの使用 |
AU2020315758B2 (en) | 2019-07-16 | 2024-08-01 | Donaghys Limited | Transdermal solvent system and methods of use |
EP4054549A4 (fr) | 2019-11-06 | 2023-12-06 | Smartech Topical, Inc. | Formulations topiques d'inhibiteurs de la cyclo-oxygénase et leur utilisation |
CN112206206B (zh) * | 2020-10-15 | 2023-02-10 | 复旦大学附属中山医院青浦分院 | 一种阴道给药的姜黄素微乳凝胶剂的制备方法和应用 |
US20240108633A1 (en) * | 2020-12-29 | 2024-04-04 | Onquality Pharmaceuticals China Ltd. | Method for preventing or treating disease or condition associated with antitumor agent |
WO2023139907A1 (fr) | 2022-01-24 | 2023-07-27 | 株式会社Moresco | Nanoémulsion dotée d'un effet antiseptique |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5720948A (en) * | 1995-11-07 | 1998-02-24 | Helene Curtis Inc. | Non-ionic surfactant emulsion vehicles and their use for deposition of drug into and across skin |
FR2742676B1 (fr) * | 1995-12-21 | 1998-02-06 | Oreal | Nanoemulsion transparente a base de tensioactifs silicones et utilisation en cosmetique ou en dermopharmacie |
SE9800729L (sv) * | 1998-03-06 | 1999-09-07 | Scotia Lipidteknik Ab | Ny topikal formulering I |
JP2004506614A (ja) * | 2000-07-10 | 2004-03-04 | ザ、プロクター、エンド、ギャンブル、カンパニー | 化粧品組成物 |
CN100381175C (zh) * | 2004-10-09 | 2008-04-16 | 山西中医学院 | 一种微乳制剂及其制备方法 |
US8962629B2 (en) * | 2008-06-10 | 2015-02-24 | Abbvie Inc. | Tricyclic compounds |
CN101904814A (zh) * | 2009-06-04 | 2010-12-08 | 上海恒瑞医药有限公司 | 制备载药乳剂的方法 |
FR2947276B1 (fr) * | 2009-06-24 | 2012-10-26 | Seppic Sa | Composition cosmetique a base de resines echangeuses d'ions chargees avec des lipoaminoacides |
US8297441B2 (en) * | 2009-08-04 | 2012-10-30 | Pepsico, Inc. | Protective contact strips for beverage trays |
FR2991171B1 (fr) * | 2012-06-01 | 2014-05-23 | Galderma Res & Dev | Procede de preparation d'une composition dermatologique comprenant des oleosomes |
US20160120835A1 (en) * | 2013-06-12 | 2016-05-05 | Leo Laboratories Limited | A topical composition |
-
2015
- 2015-08-27 CA CA2957579A patent/CA2957579A1/fr not_active Abandoned
- 2015-08-27 AU AU2015308878A patent/AU2015308878A1/en not_active Abandoned
- 2015-08-27 JP JP2017511265A patent/JP2017529334A/ja not_active Ceased
- 2015-08-27 WO PCT/US2015/047152 patent/WO2016033308A1/fr active Application Filing
- 2015-08-27 SG SG11201701292XA patent/SG11201701292XA/en unknown
- 2015-08-27 MX MX2017002438A patent/MX2017002438A/es unknown
- 2015-08-27 US US15/506,310 patent/US20170266289A1/en not_active Abandoned
- 2015-08-27 EP EP15759606.5A patent/EP3185852A1/fr not_active Withdrawn
- 2015-08-27 CN CN201580046792.9A patent/CN106794126A/zh active Pending
- 2015-08-27 BR BR112017004032A patent/BR112017004032A2/pt not_active Application Discontinuation
-
2020
- 2020-07-21 JP JP2020124225A patent/JP2020183427A/ja active Pending
- 2020-10-27 AU AU2020260396A patent/AU2020260396A1/en not_active Abandoned
-
2022
- 2022-09-20 JP JP2022148794A patent/JP2022180494A/ja active Pending
- 2022-09-28 AU AU2022241500A patent/AU2022241500A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2015308878A1 (en) | 2017-03-02 |
CA2957579A1 (fr) | 2016-03-03 |
AU2020260396A1 (en) | 2020-11-19 |
JP2022180494A (ja) | 2022-12-06 |
CN106794126A (zh) | 2017-05-31 |
MX2017002438A (es) | 2017-05-23 |
EP3185852A1 (fr) | 2017-07-05 |
US20170266289A1 (en) | 2017-09-21 |
AU2022241500A1 (en) | 2022-10-27 |
JP2020183427A (ja) | 2020-11-12 |
JP2017529334A (ja) | 2017-10-05 |
WO2016033308A1 (fr) | 2016-03-03 |
BR112017004032A2 (pt) | 2017-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201701292XA (en) | Topical formulation | |
GB201407934D0 (en) | Formulation | |
GB201513010D0 (en) | Novel formulation | |
HK1231396A1 (zh) | 外用組合物 | |
HK1231376A1 (zh) | 局部製劑及其應用 | |
GB201709918D0 (en) | Topical formulation | |
GB201514758D0 (en) | Formulation | |
GB201410198D0 (en) | Antiperspirant formulation | |
IL248835A0 (en) | A preparation of ciritinib | |
HUE054584T2 (hu) | Maropitant készítmény | |
GB201407384D0 (en) | Formulation | |
GB201400647D0 (en) | Topical composition | |
IL251362A0 (en) | formulation | |
ZA201605935B (en) | Topical antibiotic formulations | |
GB201521771D0 (en) | Formulation | |
GB201511255D0 (en) | Formulation | |
GB201509891D0 (en) | Formulation | |
GB201402448D0 (en) | Novel formulation | |
GB201511301D0 (en) | Formulation | |
GB201514014D0 (en) | Formulation | |
GB201416536D0 (en) | Formulation | |
GB201416274D0 (en) | Formulation | |
GB201504662D0 (en) | Formulation | |
GB201412754D0 (en) | Formulation | |
GB201508527D0 (en) | Novel formulation |